FDA warns against clarithromycin use in patients with heart disease
February 23, 2018
Clarithromycin may lead to an increased chance of heart problems or death years after use.
Blood test approved for patients with concussions
February 15, 2018
The new test can quickly determine who needs CT scans – and will hopefully reduce costs.
Drug combo indicated for bacterial pneumonia
February 4, 2018
Ceftazidime/avibactam is the first new option in years for treatment of HABP/VABP caused by Gram-negative bacteria.
FDA: No more codeine or hydrocodone cold medicines for children
January 11, 2018
Risks outweigh benefits for pediatric prescription cough and cold medicines containing opioids.
FDA approves premixed, low-volume colon-cleansing solution
December 13, 2017
The best way to ensure a good colonoscopy is with an effective prep.
New buprenorphine formulation approved for medication-assisted treatment
December 2, 2017
Patients who are currently taking other buprenorphine formulations can be transitioned.
CDC data show decline in some hospital-acquired infections
October 16, 2017
SAN DIEGO - Reduced use of urinary catheters and central lines appears to be having an effect in controlling some HAIs.
Do not withhold opioid addiction drugs from patients taking benzodiazepines
September 21, 2017
The FDA says the benefits of combining MAT drugs with CNS depressants outweigh the risks.
FDA approves Vabomere for complicated UTI in adults
August 31, 2017
The new drug, administered by intravenous infusion, is expected to be available before the end of the year.
Standardized infection ratio for CLABSI almost halved since 2009
August 21, 2017
Other hospital-related infections can’t match drop in SIR for central line–associated bloodstream infections.